CN104825512B - 一种治疗肿瘤的联合用药物 - Google Patents
一种治疗肿瘤的联合用药物 Download PDFInfo
- Publication number
- CN104825512B CN104825512B CN201510191764.8A CN201510191764A CN104825512B CN 104825512 B CN104825512 B CN 104825512B CN 201510191764 A CN201510191764 A CN 201510191764A CN 104825512 B CN104825512 B CN 104825512B
- Authority
- CN
- China
- Prior art keywords
- paclitaxel
- tumor
- raw sangqi
- combination medicine
- sangqi ginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510191764.8A CN104825512B (zh) | 2015-04-21 | 2015-04-21 | 一种治疗肿瘤的联合用药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510191764.8A CN104825512B (zh) | 2015-04-21 | 2015-04-21 | 一种治疗肿瘤的联合用药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104825512A CN104825512A (zh) | 2015-08-12 |
CN104825512B true CN104825512B (zh) | 2016-03-30 |
Family
ID=53803964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510191764.8A Active CN104825512B (zh) | 2015-04-21 | 2015-04-21 | 一种治疗肿瘤的联合用药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104825512B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113413408A (zh) * | 2021-07-16 | 2021-09-21 | 安徽康信制药股份有限公司 | 一种具有抗肿瘤作用的中药胶囊及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1208630A (zh) * | 1997-08-14 | 1999-02-24 | 崔兴 | 一种抗癌药剂系列及其生产方法 |
CN102327498A (zh) * | 2011-10-09 | 2012-01-25 | 熊刚 | 含有紫杉醇浸膏的抗癌新药 |
-
2015
- 2015-04-21 CN CN201510191764.8A patent/CN104825512B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104825512A (zh) | 2015-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tunjung et al. | Anti-cancer effect of kaffir lime (Citrus hystrix DC) leaf extract in cervical cancer and neuroblastoma cell lines | |
CN104398526B (zh) | 雷公藤甲素和雷公藤红素在制备抗肿瘤药物中的应用 | |
CN104825512B (zh) | 一种治疗肿瘤的联合用药物 | |
CN102861193A (zh) | 一种治疗胃癌的中药组合物 | |
CN106974906A (zh) | 穿心莲内酯在制备提高博来霉素抗肿瘤效果的药物中的应用 | |
Wu et al. | A case of chemotherapy-induced congestive heart failure successfully treated with Chinese herbal medicine | |
CN104814989B (zh) | 一种治疗肿瘤的联合用药物 | |
CN102389559B (zh) | 一种中药组合物及其作为放疗增敏剂的应用 | |
Wang et al. | The traditional Chinese medicine and non-small cell lung cancer: from a gut microbiome perspective | |
CN102526024B (zh) | 一种抗癌药物组合物 | |
Xiong et al. | Protective effects of tannins in Sanguisorbae Radix on myelosuppression mice | |
CN106309758B (zh) | 一种抗胃肠癌的药物组合物 | |
CN104189782A (zh) | 一种抗肿瘤的药物组合物 | |
CN104127427B (zh) | 一种抗癌增效组合物 | |
CN104147031B (zh) | 一种含有秦皮甲素的抗肿瘤药物组合物 | |
CN102423384B (zh) | 一种治疗肺癌的中药制剂及其制备方法 | |
CN103463098B (zh) | 常春藤皂苷元在制备抗肿瘤药物中的应用 | |
CN107441076B (zh) | 一种治疗癌症的联合用药物 | |
CN105477432A (zh) | 一种治疗肿瘤的药物组合物 | |
CN105267793B (zh) | 一种中药组合物的新用途 | |
CN103191268B (zh) | 一种治疗肺癌的中药组合物 | |
Chen et al. | Possible Mechanism of Astragalus notoginseng Compound Glycosides Reversing Chemoresistance of Breast Cancer | |
CN105343094A (zh) | 一种抗癌细胞转移的药物组合物 | |
Fang et al. | Quantitative analysis of effects of salvianic acid a combined with hydroxy safflower yellow a on rat endothelial cells after hypoxic injury using the combination index method | |
Chang et al. | Experimental study on growth inhibition against anaplastic thyroid carcinoma of animal model by application of ginsenoside Rg1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170221 Address after: Science Park high tech Zone of Chengdu South Road, No. 88 610041 Sichuan province Tianfu Life Science Park B7-401 Patentee after: Chengdu Hexun Pharmaceutical Co., Ltd. Address before: 610000 Sichuan City, Chengdu Province, Qingyang Road, No. 229, No. 6, building 1, No. 5 Patentee before: Sichuan is unified into fast health medicine limited company |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190814 Address after: 625699 Qianhouba Formation of Qingjiang Village, Siyan Township, Lushan County, Ya'an City, Sichuan Province Patentee after: Ya'an Xun Kang Pharmaceutical Co., Ltd. Address before: Science Park high tech Zone of Chengdu South Road, No. 88 610041 Sichuan province Tianfu Life Science Park B7-401 Patentee before: Chengdu Hexun Pharmaceutical Co., Ltd. |